Ranolazine
NDC Package 42385-964-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ranolazine is a . Marketed by Laurus Generics Inc., this product is identified by NDC 42385-964 and is authorized under FDA application ANDA214035.

Identification & Billing

NDC Package Code
42385-964-60
Package Description
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Code
42385-964
11-Digit Billing Format
42385096460
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
60 EA

Clinical Specifications

Proprietary Name
Ranolazine
Dosage Form
-

Regulatory & Marketing

Labeler Name
Laurus Generics Inc.
FDA Application #
ANDA214035
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-19-2022
End Marketing Date
05-31-2025
Listing Expiration
05-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42385-964-60 identifies a specific commercial package of 60 tablet, film coated, extended release in 1 bottle, plastic of Ranolazine, labeled by Laurus Generics Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Laurus Generics Inc. on January 19, 2022. The current certification is valid through May 31, 2025.

How is this Laurus Generics Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42385096460. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42385-964-60
11-Digit CMS (5-4-2)
42385-0964-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.